Literature DB >> 27225253

Model Validation: Has it's Time Come?

Jonathan Karnon1.   

Abstract

Year:  2016        PMID： 27225253     DOI： 10.1007/s40273-016-0415-y

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  5 in total

1.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Value Health       Date:  2013 Mar-Apr       Impact factor: 5.725

Review 2.  Model performance evaluation (validation and calibration) in model-based studies of therapeutic interventions for cardiovascular diseases : a review and suggested reporting framework.

Authors:  Hossein Haji Ali Afzali; Jodi Gray; Jonathan Karnon
Journal:  Appl Health Econ Health Policy       Date:  2013-04       Impact factor: 2.561

3.  Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.

Authors:  David M Eddy; William Hollingworth; J Jaime Caro; Joel Tsevat; Kathryn M McDonald; John B Wong
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

4.  AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.

Authors:  P Vemer; I Corro Ramos; G A K van Voorn; M J Al; T L Feenstra
Journal:  Pharmacoeconomics       Date:  2016-04       Impact factor: 4.981

Review 5.  Unremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast Cancer.

Authors:  Pieter T de Boer; Geert W J Frederix; Talitha L Feenstra; Pepijn Vemer
Journal:  Pharmacoeconomics       Date:  2016-09       Impact factor: 4.981
  5 in total
  2 in total

1.  Ahead of Our Time: Collaboration in Modeling Then and Now.

Authors:  Renée J G Arnold; Sean Ekins
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

2.  Four Aspects Affecting Health Economic Decision Models and Their Validation.

Authors:  Talitha Feenstra; Isaac Corro-Ramos; Dominique Hamerlijnck; George van Voorn; Salah Ghabri
Journal:  Pharmacoeconomics       Date:  2021-12-16       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.